Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Indivior PLC is a global pharmaceutical company dedicated to transforming the treatment of substance use disorders (SUDs), particularly opioid use disorder (OUD). Its key products include SUBLOCADE, SUBOXONE Film, and OPVEE, addressing both OUD and opioid overdose. With a significant market opportunity driven by rising addiction rates, Indivior targets healthcare providers and patients in over 30 countries. The company emphasizes compliance and innovation, recently launching OPVEE and expanding SUBLOCADE's administration options.
This description was generated via AI from an annual report. Updated about 1 year ago.